Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes

HF VanBrocklin, JK Lim, SL Coffing…

Index: Journal of Medicinal Chemistry, , vol. 48, # 23 p. 7445 - 7456

Full Text: HTML

Citation Number: 33

Abstract

... Journal of Medicinal Chemistry. ... Likewise, navigating the structure−activity relationships in the medicinal chemistry literature can be challenging with respect to choosing an appropriate imaging lead compound. ... Results. Chemistry. ...

Related Articles:

Anilinoquinazoline inhibitors of fructose 1, 6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography

[Wright, Stephen W.; Carlo, Anthony A.; Carty, Maynard D.; Danley, Dennis E.; Hageman, David L.; Karam, George A.; Levy, Carolyn B.; Mansour, Mahmoud N.; Mathiowetz, Alan M.; McClure, Lester D.; Nestor, Nestor B.; McPherson, R. Kirk; Pandit, Jayvardhan; Pustilnik, Leslie R.; Schulte, Gayle K.; Soeller, Walter C.; Treadway, Judith L.; Wan, Ing-Kae; Bauer, Paul H. Journal of Medicinal Chemistry, 2002 , vol. 45, # 18 p. 3865 - 3877]

Anilinoquinazoline inhibitors of fructose 1, 6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography

[Journal of Medicinal Chemistry, , vol. 45, # 18 p. 3865 - 3877]

Anilinoquinazoline inhibitors of fructose 1, 6-bisphosphatase bind at a novel allosteric site: synthesis, in vitro characterization, and X-ray crystallography

[Journal of Medicinal Chemistry, , vol. 45, # 18 p. 3865 - 3877]

More Articles...